Experts discuss additional factors considered when determining the most effective sequence of therapies for metastatic colorectal cancer, including fruquintinib, regorafenib, and trifluridine + ...

Colorectal cancer is one of the most prevalent tumors and a leading cause of cancer-related mortality. Despite advances ...

Immunotherapy uses the power of your immune system to fight your cancer. One type of immunotherapy is called an immune checkpoint inhibitor. Your immune system has built-in checkpoints that help it ...

The surgical outcomes of colon cancer vary with its anatomical location. Neoadjuvant chemotherapy can aid in improving the postsurgical outcomes of both right and left colon cancer, decreasing the ...

CX-2051 demonstrated a 28% overall response rate in advanced colorectal cancer, with a 43% response at the highest dose of 10 mg/kg. The disease control rate was 94%, and median progression-free ...

The results of the phase 3 ATOMIC trial fired another volley in the ongoing debate over adjuvant vs neoadjuvant immunotherapy for patients with locally advanced colon cancer. But experts are divided ...

Colon cancer diagnosis involves colonoscopy, imaging, and blood tests, with staging guiding treatment decisions. Stage 1 treatment typically involves surgery, while stage 2 may include chemotherapy ...

Colorectal cancer has become the leading cause of cancer-related deaths among people under the age of 50, according to new data from the American Cancer Society (ACS). The finding has raised serious ...

Colorectal cancers have seen a 1% increase in deaths every year since 2005, while the mortality rate of every other type of ...

A new report found that colorectal cancer causes more deaths than any other type of cancer, including breast and lung cancers ...